Investor Relations

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them.


News Releases

News Releases

The information set forth in each press release posted on this page was factually accurate on the date it was issued. While these press releases remain on the Company's website, the Company assumes no duty to update the information to reflect subsequent developments. Consequently, readers of the press releases should not rely upon the information as current or accurate after their issuance dates.

Date Title
Charles River Laboratories Schedules First-Quarter 2021 Earnings Release and Conference Call
Charles River and Valence Discovery Announce Strategic Partnership to Provide Clients with AI-Enabled Drug Design Capabilities
Charles River Laboratories Acquires Retrogenix
Charles River Laboratories Completes the Acquisition of Cognate BioServices
Charles River Laboratories Announces Closing of Senior Notes Offering
Charles River Laboratories Prices $1 Billion of Senior Notes
Charles River Laboratories Announces Planned Offering of $1 Billion of Senior Notes
Charles River Laboratories to Present at Barclays Global Healthcare Conference
Charles River Laboratories Announces Strategic Partnership with Kibur Medical to Advance Preclinical Oncology Studies
Charles River Laboratories Announces Fourth-Quarter and Full-Year 2020 Results and Provides 2021 Guidance
Charles River Laboratories to Acquire Cognate BioServices to Create a Premier Scientific Partner for Cell and Gene Therapy Development
Charles River Announces Strategic Partnership with Cypre, Expanding 3D In Vitro Services for Cancer Immunotherapy and Targeted Therapy Drug Screening
Charles River Laboratories Schedules Fourth-Quarter 2020 Earnings and 2021 Guidance Release and Conference Call
Charles River Partners with JADE Biomedical to Expand Biologics Capabilities
Charles River Laboratories to Present at J.P. Morgan Healthcare Conference
Charles River Laboratories Acquires Distributed Bio

Featured Report

2020 Annual Report (PDF)

Charles River Corporate Citizenship Report
View PDF
Print PDF